Cargando…
Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination
Anti-leucine rich glioma inactivated 1 (LGI1) autoimmune encephalitis (AE) is characterized by cognitive impairment or rapid progressive dementia, psychiatric disorders, faciobrachial dystonic seizures (FBDS) and refractory hyponatremia. Since December 2020, millions of people worldwide have been va...
Autores principales: | Zlotnik, Yair, Gadoth, Avi, Abu-Salameh, Ibrahim, Horev, Anat, Novoa, Rosa, Ifergane, Gal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766789/ https://www.ncbi.nlm.nih.gov/pubmed/35069602 http://dx.doi.org/10.3389/fimmu.2021.813487 |
Ejemplares similares
-
Fibromyalgia-Like Syndrome Associated with Parkinson’s Disease—A Cohort Study
por: Abuhasira, Ran, et al.
Publicado: (2019) -
Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
por: Cui, Li-li, et al.
Publicado: (2021) -
Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19
por: Li, Yanfei, et al.
Publicado: (2023) -
A Comparison Between Pressure Wire and Microcatheter Measurements for Evaluating the Cerebral Venous Pressure Gradient
por: Horev, Anat, et al.
Publicado: (2021) -
Comprehensive B-Cell Immune Repertoire Analysis of Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis
por: Feng, Jingjing, et al.
Publicado: (2021)